| 1.1 | SITAGLIPTIN | 762240-92-6 | 3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine Hydrochloride | ANTI-DIABETIC |  |
| 2.2 | EMPAGLIFLOZIN | 915095-85-1 | (5-Bromo-2-Chlorophenyl)(4-Fluorophenyl)Methanone | ANTI-DIABETIC | |
| 3.1 | DAPAGLIFLOZIN | 461432-22-4 | (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone | ANTI-DIABETIC | |
| 3.2 | DAPAGLIFLOZIN | 461432-23-5 | 1-(5-Bromo-2-Chlorobenzyl)-4-Ethoxybenzene/5-Bromo-2-Chloro-4’-Ethoxydiphenylmethane | ANTI-DIABETIC | |
| 3.3 | DAPAGLIFLOZIN | 461432-25-7 | D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-2,3,4,6-tetraacetate,(1S)- (OR[(2R,3R,4R,5S,6S)-3,4,5-tris(acetyloxy)-6-{4-chloro-3-[(4-ethoxyphenyl)methyl] phenyl}oxan-2-yl]methyl acetate | ANTI-DIABETIC | |
| 5.1 | RIVAROXABAN | 438056-69-0 | [4-(4-Aminophenyl)Moropholin-3-One] (KSM) | ANTI-THROMBOTIC | |
| 5.2 | RIVAROXABAN | 161596-47-0 | ([2-[(2S)-Oxiran-2-Ylmethyl]-1H-Isoindole-1,3(2H)-Dione (KSM) | ANTI-THROMBOTIC | |
| 5.3 | RIVAROXABAN | 24065-33-6 | 5-Chlorothiophene-2-Carboxyilic Acid (KSM) | ANTI-THROMBOTIC | |
| 5.4 | RIVAROXABAN | 898543-06-1 | 4-{4-{(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride | ANTI-THROMBOTIC | |
| 5.6 | RIVAROXABAN | 898543-06-1 | 4-{4-[(5S)-5-(Aminomethyl)-2-Oxo-1,3-Oxazolidin-3-Yl]Phenyl}Morpholin-3-One Hydrochloride. | ANTI-THROMBOTIC | |
| 7.1 | CELECOXIB | 17852-52-7 | 4-Hydrazino Benzene Sulphonomide Hcl | ANTI-INFLAMMATORY | |
